{"nctId":"NCT04537078","briefTitle":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","startDateStruct":{"date":"2020-09-01","type":"ACTUAL"},"conditions":["Infertility, Female"],"count":90,"armGroups":[{"label":"the progestin primed double stimulation group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Duphaston","Drug: Gonadotropin","Drug: Decapeptyl","Drug: Combined Oral Contraceptive","Drug: Cyclo-Progynova","Drug: progesterone"]},{"label":"the flexible GnRh antagonist","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Gonadotropin","Drug: Cetrotide Injectable Product","Drug: Decapeptyl","Drug: Chorionic Gonadotropin","Drug: Combined Oral Contraceptive","Drug: Cyclo-Progynova","Drug: progesterone"]}],"interventions":[{"name":"Duphaston","otherNames":[]},{"name":"Gonadotropin","otherNames":["Fostimon","Menopure","Menogon","Gonapure"]},{"name":"Cetrotide Injectable Product","otherNames":[]},{"name":"Decapeptyl","otherNames":[]},{"name":"Chorionic Gonadotropin","otherNames":["choriomon"]},{"name":"Combined Oral Contraceptive","otherNames":["Gynera"]},{"name":"Cyclo-Progynova","otherNames":[]},{"name":"progesterone","otherNames":["prontogest"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\npoor ovarian responders patients defined by Bologna criteria\n\nExclusion Criteria:\n\n1. Male factor infertility due to azoospermia.\n2. Patients with uncorrected uterine pathology.\n3. Patients with the diagnosis of severe endometriosis.\n4. Patients with BMI over 35.","healthyVolunteers":true,"sex":"FEMALE","genderBased":true,"minimumAge":"20 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"the Number of M2 Oocytes Retrieved","description":"it is the number of M2 oocytes retrieved that were being assessed after denudation","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"4.5","spread":null}]}]}]},{"type":"PRIMARY","title":"the Fertilization Rate","description":"percentage transformation of micro injected oocytes into two pronuclei. it is done 16 to 20 hours after microinjection of the oocytes by the sperms","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"71.43","spread":null},{"groupId":"OG001","value":"80.91","spread":null}]}]}]},{"type":"PRIMARY","title":"the Resultant Embryos Number","description":"it is the resultant embryos number counted day 3 or 4 or 5 after fertilization","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"the Implantation Rate","description":"it is calculated as the number of intrauterine gestational sacs observed by transvaginal ultrasonography divided by the number of transferred embryos at the 6 th week of pregnancy and then multiplied by 100","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]}]},{"type":"PRIMARY","title":"the Clinical Pregnancy Rate.","description":"percentage of cases in which observation of a gestational sac with fetal heart beat by transvaginal ultrasound at 6 weeks of pregnancy","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference in the Ongoing Pregnancy Rate in Both Protocols.","description":"Assessing the difference in the ongoing pregnancy rate when the pregnancy had completed â‰¥20 weeks of gestation","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Days of Controlled Ovarian Hyperstimulation","description":"the total number of days of the controlled ovarian hyperstimulation in both follicular and luteal phase of the progestin primed double stimulation protocol are studied so as to asses the difference between the two phases, the follicular phase and the luteal phase of the progestin primed double stimulation protocol","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Dosage of Gonadotropins Used in the Controlled Ovarian Hyperstimulation","description":"Assessing the difference between the follicular phase and the luteal phase of the progestin primed double stimulation protocol regarding the total dosage of gonadotropins used in the controlled ovarian hyperstimulation so as to the difference between the two phases","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3000","spread":null},{"groupId":"OG001","value":"3600","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Number of M2 Oocytes Retrieved","description":"it is the number of M2 oocytes retrieved that were being assessed after denudation so as to the difference between the results between the two phases, the follicular phase and the luteal phase of the progestin primed double stimulation protocol","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Fertilization Rate.","description":"percentage of transformation of micro injected oocytes into two pronuclei at 16 -20 hours after microinjection of the oocytes by the sperms so as to the difference between the results between the two phases, the follicular phase and the luteal phase of the progestin primed double stimulation protocol","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.67","spread":null},{"groupId":"OG001","value":"100","spread":null}]}]}]},{"type":"SECONDARY","title":"the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Resultant Embryos Number","description":"the resultant embryos number are counted day 3 or 4 or 5 after fertilization so as to the difference between the results between the two phases, the follicular phase and the luteal phase of the progestin primed double stimulation protocol","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessing the Difference Between the Follicular Phase of the Progestin Primed Double Stimulation Protocol and the First Round of the Conventional GnRH Antagonist Protocol Regarding the Number of M2 Oocytes Retrieved .","description":"it is the number of M2 oocytes retrieved that were being assessed after denudation.so as to study the effect of the progestin used on the ovarian response in poor ovarian responders, we have compared the follicular phase of the dual stimulation group and first follicular wave of the flexible antagonist group","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessing the Difference Between the Follicular Phase of the Progestin Primed Double Stimulation Protocol and the First Round of the Conventional GnRH Antagonist Protocol Regarding the Fertilization Rate.","description":"it is percentage transformation of micro injected oocytes into two pronuclei.so as to study the effect of the progestin used on the ovarian response and its results in poor ovarian responders, we have compared the follicular phase of the dual stimulation group and first follicular wave of the flexible antagonist group","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.67","spread":null},{"groupId":"OG001","value":"91.67","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessing the Difference Between the Follicular Phase of the Progestin Primed Double Stimulation Protocol and the First Round of the Conventional GnRH Antagonist Protocol Regarding the Resultant Embryos Number.","description":"it is the number of the resultant embryos counted at day 3 or 4 or 5 after fertilization.so as to study the effect of the progestin used on the ovarian response and the resultant embryos number in poor ovarian responders, we have compared the follicular phase of the dual stimulation group and first follicular wave of the flexible antagonist group","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.66","spread":"1.44"},{"groupId":"OG001","value":"1.69","spread":"1.18"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":["nausea and abdominal distention","pelvic pain","headache"]}}}